Pfizer (PFE) CEO says drug prices are coming down - CNBC

The CEO of Pfizer has indicated that drug prices are set to decrease, which may signal a shift in pricing strategy that could influence the company's margins and overall profitability.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

US Energy Secretary says in early stages of Greenland negotiations; there is uncertainty now but will get a great result - CNBC

Fitch Ratings says the US credit outlook is broadly benign entering 2026, supported by AI-led capex, easing monetary policy and strong fiscal support

Pfizer (PFE) CEO says drug prices are coming down - CNBC

US President Trump on Truth posts "No single person, or President, has done more for NATO than President Donald J. Trump. If I didn’t come along, there would be no NATO right now!!! It would have been in the ash heap of History. Sad, but TRUE!!!"

Paris court rules Apple (AAPL) can keep its ATT feature

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This announcement could also affect sentiment across the pharmaceuticals sector, particularly if it leads to increased competition or impacts regulatory discussions. Traders should watch for potential volatility in Pfizer's stock and broader market reactions within healthcare equities.

Related headlines

The whole workspace, free to try.

Try it free